GlassScriptPhysician profile
Mithaq Vahedi
NPI 1942565890
$5,802.50
in general payments reported to CMS, 2019-2025
11 companies · $68.44 in 2025
The $68.44 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $532 · 2020: $263 · 2021: $272 · 2022: $2,097 · 2023: $2,038 · 2024: $532 · 2025: $68.44.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,604 · Travel and Lodging: $1,034.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,604.09 |
| Travel and Lodging | $1,034.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,271.70 | 2022-2025 | Durysta, Xen Glaucoma Treatment System, Lumigan |
| Alcon Vision LLC | $2,031.05 | 2019-2024 | Hydrus Microstent |
| Sight Sciences, INC. | $649.42 | 2022-2024 | Omni Surgical System, Sion Surgical Instrument |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $288.91 | 2019-2021 | |
| Regeneron Pharmaceuticals, INC. | $124.98 | 2019 | |
| Aerie Pharmaceuticals, INC. | $119.32 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $116.42 | 2019 | |
| Mallinckrodt Enterprises LLC | $75.35 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $57.87 | 2019 | |
| Bausch & Lomb Americas INC. | $37.93 | 2022 | |
| Allergan, INC. | $29.55 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mithaq Vahedi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.